Tag: Arthritis: Misc.
May 2017 Briefing – Rheumatology
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for May 2017. This roundup includes the latest...
CDC: Prevalence of Arthritis 31.8% in Most Rural Areas of U.S.
About half of those with arthritis in rural and urban areas have arthritis-attributable activity limitation
Severe Cutaneous Adverse Effect From Tocilizumab Described
Diffuse, persistent, pruritic maculopapular rash developed 10 days after tocilizumab treatment
Ixekizumab Improves Symptoms in Patients With Psoriatic Arthritis
Two-week and four-week ixekizumab dosing regimens improved signs and symptoms
Arthroscopy for Degenerative Knees Deemed Seldom Effective
Widely used procedure won't help arthritic degeneration, according to new recommendation
April 2017 Briefing – Rheumatology
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for April 2017. This roundup includes the latest...
MTX + Adalimumab Beneficial in JIA-Associated Uveitis
In children with active juvenile idiopathic arthritis, the combination controls eye inflammation
Musculoskeletal Symptoms Predict Psoriatic Arthritis
Joint pain, fatigue, stiffness, worsening of physical function all predict PsA in patients with psoriasis
CDC: Arthritis Limits the Activities of 24 Million U.S. Adults
One in four adults have been diagnosed with arthritis in the United States
February 2017 Briefing – Rheumatology
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for February 2017. This roundup includes the latest...
